Making New Vaccines Affordable: A Comparison of Financing Processes Used to Develop and Deploy New Meningococcal and Pneumococcal Conjugate Vaccines

Two innovative mechanisms have been used to accelerate the development of low-price supply lines for conjugate vaccines. The Meningitis Vaccine Project is a so-called push mechanism that facilitated technology transfer to an Indian company to establish capacity to manufacture a vaccine. The Advanced Market Commitment for pneumococcal vaccines is a so-called pull mechanism that guarantees companies a supplement paid in addition to the purchase price for vaccines for a specific period. This article, published in The Lancet, compares these approaches, identifying key dimensions of each and considering their potential for replication. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.) 

Author(s): Hargreaves JR, Greenwood B, Clift C, et al.

Published: 2011

  • Visit web page (English)

    (Located at www.thelancet.com)

    Citation: Hargreaves JR, Greenwood B, Clift C, et al. Making New Vaccines Affordable: A Comparison of Financing Processes Used to Develop and Deploy New Meningococcal and Pneumococcal Conjugate Vaccines. The Lancet. 2011;378(9806):1885-1893.